Improving patient outcomes by pooling resources (the Texas Heart Care Partnership Experience)

American Journal of Cardiology

Volumn 85, Issue 3 SUPPL. 1, 2000, Pages 43-51

  Hillert, Bob ^a,b   Remonte, Sonia ^b   Rodgers, George ^c   Yancy, Clyde W ^d   Kaul, Alan F ^e,f  

^a Texas Medical Association   (United States)

^b Doctors Hospital   (United States)

^c Austin Heart   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Medical Outcomes Management Inc   (United States)

^f UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; ESTROGEN THERAPY; EXERCISE; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SMOKING CESSATION; UNITED STATES; WEIGHT REDUCTION;

CARDIOLOGY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; HEALTH RESOURCES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; TEXAS;

EID: 0033951795     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00938-8     Document Type: Article

References (30)

1. Smith S.C. Jr, Blair S.N., Criqui M.H., Fletcher G.F., Fuster V., Gersh B.J., Gotto A.M., Gould K.L., Greenland P., Grundy S.M., et al. AHA consensus panel statement preventing heart attack and death in patients with coronary disease: the Secondary Prevention Panel . J Am Coll Cardiol. 26:1995;292-294.
2. Sueta C.A., Chowdhury M., Boccuzzi S.J., Smith C., Alexander C.M., Londhe A., Lulla A., Simpson R.J. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol. 83:1999;1303-1307.
3. Keilson L. Lipid and risk factor management in the hospital setting an opportunity to prevent recurrent disease . Issues Prev Cardiol. 1.3:1998;2-7.
4. Cleeman J.I., Lenfant C. The National Cholesterol Education Program. JAMA. 280:1998;2099-2104.
5. McBride P.E., Schrott H.G., Plane M.B., Underbakke G., Brown R.L. Primary care practice adherence to national cholesterol education program guidelines for patients with coronary heart disease. Arch Intern Med. 158:1998;1238-1244.
6. Grundy S.M., Balady G.J., Criaui M.H., Fletcher G., Greenland P., Hiratzka L.F., Houston-Miller N., Kris-Etherton P., Krumholz H.M., LaRosa J., et al. When to start cholesterol-lowering therapy in patients with coronary heart disease a statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction . Circulation. 95:1997;1683-1685.
7. Pearson TA, Peters TD, Feury D. Comprehensive risk reduction in coronary patients: attainment of Goals of the AHA Guidelines in U.S. patients - American Heart Association Abstracts from the 70th Scientific Sessions. Orlando, FL, 1997.
8. Simpson R.J. Jr, Sueta C.A., Boccuzzi S.J., Lulla A., Biggs D., Londhe A., Smith S.C. Jr. Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction. Am J Cardiol. 80:(suppl 8B):1997;53H-56H.
9. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
10. NHLBI Cholesterol Awareness Surveys. Bethesda, MD: National Heart, Lung and Blood Institute, 1995.
11. Statistical Services Division Bureau of Vital Statistics Texas Department of Health, 1998.
12. U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion. State Cardiovascular Disease Highlights 1997: The Burden of Cardiovascular Disease in the United States, 1997.
13. U.S. Department of Health and Human Services Health Care Financing Administration Bureau of Data Management and Strategy. 1997 Data Compendium, 1997.
14. American Heart Association. 1998 Heart and Stroke Statistical Update. Dallas: American Heart Association, 1997.
15. National Stroke Association: Stroke Clinical Updates 1994;5(3).
16. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:1998;234.
17. Potts J.L., Thomas J. Traditional coronary risk factors in African Americans. Am J Med Sci. 317:1999;189-192.
18. Clark L.T. Primary prevention of cardiovascular disease in high risk patients physiologic and demographic risk factor differences between African and white American populations . Am J Med. 107:1999;22S-24S.
19. Harris M.I. Diabetes in America epidemiology and scope of the problem . Diabetes Care. 21:(suppl 3):1998;C11-C14.
20. Texas Department of Health Bureau of Chronic Disease Prevention and Control. Behavoiral Risk Factor Surveillance System. 1998.
21. Encouraging patients to become more physically active: the physician's role. Ann Intern Med 1997;127:395-400.
22. Pearson T.A., Peters T.D. The treatment gap in coronary artery disease and heart failure community standards and the post-discharge patient . Am J Cardiol. 80:(suppl):1997;45H-52H.
23. State of the State of Cardiovascular Disease and Stroke in Texas. Texas Medical Association. Texas Coalition on CVD and Stroke. 1999:129. http://www.texmed.org/health-science/health-promotion/hs-cvdreport.htm.
24. Pendergrass P. Texas Department of Health Bureau of Communicable Diseases. 1999;11-18.
25. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
26. National Committee for Quality Assurance. HEDIS 1999 Compliance Audit: Standards, Policies and Procedures. Washington, DC, 1999.
27. Marciniak T.A., Ellerbeck E.F., Radford M.J., Kresowik T.F., Gold J.A., Krumholz H.M., Keife C.I., Allman R.M., Vogel R.A., Jencks S.F. Improving the quality of care for Medicare patients with acute myocardial infarction results from the Cooperative Cardiovascular Project . JAMA. 279:1998;1392-1394.
28. The sixth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Washington, D.C.: U.S. Department of Health and Human Services 1997; NIH publication no. 98-4080.
29. American Heart Association. 1999 Heart and stroke statistical update. Dallas: American Heart Association, 1998.
30. Schrott H.G., Bittner V., Vittinghoff E., Herrington D.M., Hulley S. Adherence to national cholesterol education program treatment goals in postmenopausal women with heart disease the heart and estrogen/progestin replacement study (HERS) . JAMA. 277:1997;1281-1286.